| Stage | MTZ | % of rev | ESOA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.2B | 100.00% | $130M | 100.00% | MTZ ×39.63 |
| Gross profit | $661M | 12.83% | $14M | 11.01% | MTZ +1.8pp |
| Operating income | $275M | 5.35% | $5M | 3.56% | MTZ +1.8pp |
| Pre-tax income | $220M | 4.27% | $4M | 3.10% | MTZ +1.2pp |
| Net income | $168M | 3.26% | $3M | 2.53% | MTZ +0.7pp |
| Stage | MTZ | ESOA | Gap · A − B |
|---|---|---|---|
| Revenue | $5.2B100.00% | $130M100.00% | MTZ ×39.63 |
| Gross profit | 12.83%$661M | 11.01%$14M | MTZ +1.8pp |
| Operating income | 5.35%$275M | 3.56%$5M | MTZ +1.8pp |
| Pre-tax income | 4.27%$220M | 3.10%$4M | MTZ +1.2pp |
| Net income |
| 3.26%$168M |
| 2.53%$3M |
| MTZ +0.7pp |
None
No disclosed counterparties: MTZ.